A randomized controlled clinical trial evaluating the effect of Trigonella foenum-graecum (fenugreek) versus glibenclamide in patients with diabetes

Background: Herbal medicines long have been used in the management of diabetes mellitus (DM). Objective: This study was conducted to ascertain if fenugreek compared with glibenclamide had any impacts on controlling blood glucose in patients with uncontrolled type II DM on conventional therapy. Metho...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:African health sciences Ročník 19; číslo 1; s. 1594 - 1601
Hlavní autoři: Najdi, Rania A, Hagras, Magda M, Kamel, Fatemah O, Magadm, Rania M
Médium: Journal Article
Jazyk:angličtina
Vydáno: Uganda Makerere University Medical School 01.03.2019
Makerere Medical School
Témata:
Adult
Aged
Blood Glucose - drug effects
Blood Glucose - metabolism
diabetes
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - drug therapy
Dose-Response Relationship, Drug
Female
glibenclamide
Glyburide - chemistry
Glycated Hemoglobin A - drug effects
Humans
Hypoglycemic Agents - pharmacology
Hypoglycemic Agents - therapeutic use
Lipids - blood
Male
Middle Aged
Phytotherapy - methods
Plant Extracts - chemistry
Plant Extracts - pharmacology
Plant Extracts - therapeutic use
Seeds
Treatment Outcome
Trigonella - chemistry
Trigonella foenum-graecum (fenugreek)
diabetes
glibenclamide
Trigonella foenum-graecum (fenugreek)
ISSN:1680-6905, 1729-0503, 1680-6905, 1729-0503
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Background: Herbal medicines long have been used in the management of diabetes mellitus (DM). Objective: This study was conducted to ascertain if fenugreek compared with glibenclamide had any impacts on controlling blood glucose in patients with uncontrolled type II DM on conventional therapy. Methods: A total of 12 patients with uncontrolled DM and on metformin were recruited and divided into two groups. Patients in group 1 received 2 g fenugreek per day, whereas those in group 2 received glibenclamide 5 mg once daily. The impacts of fenugreek on the glycemic control and lipid profile were measured before initiation of the regimen and then after 12 weeks. Results: Only 9 of the 12 study participants completed the study. Fenugreek at 2 g/day caused an insignificant drop in fasting blood glucose (P = 0.63), but the fasting insulin level increased significantly (P = 0.04). The ratio of high- to low-density lipoprotein was significantly decreased from before to after treatment (P = 0.006). Fenugreek did not cause any notable adverse impacts on hepatic and renal functions throughout the study. Conclusion: Fenugreek could be used as adjuvant therapy to anti-diabetic drugs to control blood glucose, and further studies are needed. DOI: https://dx.doi.org/10.4314/ahs.v19i1.34 Cite as: Najdi RA, Hagras MM, Kamel FO, RM M. A randomized controlled clinical trial evaluating the effect of Trigonella foenum-graecum (fenugreek) versus glibenclamide in patients with diabetes. Afri Health Sci. 2019;19(1). 1594-1601. https://dx.doi.org/10.4314/ahs.v19i1.34
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
Email addresses: Rania A Najdi (rania.magadmi@yahoo.com); Magda M Hagras, MBBS PhD (Magyhagras@hotmail.com); Fatemah O Kamel, MBBS MSc PhD (fokamel@kau.edu.sa); Rania M Magadmi, MBBS PhD (rmagadmi@kau.edu.sa).
ISSN:1680-6905
1729-0503
1680-6905
1729-0503
DOI:10.4314/ahs.v19i1.34